Related Experiment Video

Updated: Oct 17, 2026

Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture
10:38

Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture

Published on: November 22, 2019

Expression of activator protein 2 in prostate cancer is related to tumor differentiation and cell proliferation

P Lipponen1, S Aaltomaa, J Kellokoski

  • 1Department of Pathology and Forensic Medicine, University of Kuopio, Kuopio, Finland. pertti.lipponen@kuopio.fi

European Urology
|April 15, 2000
PubMed
Abstract

Insights

Activator protein 2 (AP-2) expression in prostate cancer is often cytoplasmic and reduced in poorly differentiated tumors. While nuclear AP-2 correlates with aggressive features, it ultimately shows no independent prognostic value for patient survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Activator protein 2 (AP-2) is a transcription factor involved in cell cycle regulation.
  • AP-2 can activate p21 (waf1/cip1) expression, leading to cell growth arrest.
  • Understanding AP-2 expression in prostate cancer is crucial for identifying potential prognostic markers.

Purpose of the Study:

  • To investigate the expression patterns of AP-2alpha in prostate cancer tissues.
  • To correlate AP-2alpha expression with established prognostic factors.
  • To evaluate the prognostic significance of AP-2alpha in relation to patient survival.

Main Methods:

  • Immunohistochemistry was used to detect AP-2alpha expression in 215 prostate cancer cases.
  • Results were analyzed in relation to prognostic factors such as Gleason score, T category, and DNA ploidy.
  • Statistical analysis, including multivariate analysis, was performed to assess prognostic value.

Main Results:

  • AP-2alpha expression was predominantly weak and cytoplasmic, similar to normal prostate epithelium.
  • Nuclear AP-2 expression was observed in 22% of cases and associated with high Gleason score, advanced T category, DNA aneuploidy, and high S-phase fraction.
  • Low AP-2 expression correlated with high mitotic index, Ki67 labeling, and high p21 expression.

Conclusions:

  • Cytoplasmic AP-2alpha expression is diminished in poorly differentiated prostate carcinomas.
  • Nuclear AP-2 expression is rare and linked to aggressive tumor characteristics but lacks independent prognostic value.
  • AP-2 expression does not appear to be a reliable prognostic indicator in prostate cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Eukaryotic Transcription Activators02:42

Eukaryotic Transcription Activators

Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...